Current and Future Biomarkers in Multiple Sclerosis

Current and Future Biomarkers in Multiple Sclerosis

Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of effective treatment for the progressive form of MS, partly due to insensitive readout for neurodegeneration. The recent development of sensitive assays for neurofilament light chain (NfL) has made it a poten...

Full description

Bibliographic Details
Main Authors: Jennifer Yang, Maysa Hamade, Qi Wu, Qin Wang, Robert Axtell, Shailendra Giri, Yang Mao-Draayer
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:International Journal of Molecular Sciences
Subjects:
multiple sclerosis
biomarkers
neurofilament light chain
cytokines
metabolites
sCD40L
Online Access:https://www.mdpi.com/1422-0067/23/11/5877

Similar Items

Similar Items